NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $789,000 | -4.4% | 8,643 | +0.7% | 0.41% | -8.0% |
Q1 2019 | $825,000 | +33.3% | 8,580 | +4.8% | 0.45% | +18.8% |
Q2 2018 | $619,000 | +10.9% | 8,188 | +18.7% | 0.38% | +9.6% |
Q1 2018 | $558,000 | +35.4% | 6,898 | +40.5% | 0.34% | +44.4% |
Q4 2017 | $412,000 | -11.8% | 4,908 | -9.7% | 0.24% | -15.5% |
Q3 2017 | $467,000 | +2.9% | 5,435 | 0.0% | 0.28% | +5.6% |
Q2 2017 | $454,000 | -3.8% | 5,435 | -9.0% | 0.27% | -2.9% |
Q1 2017 | $472,000 | +15.1% | 5,974 | +6.0% | 0.28% | +16.9% |
Q4 2016 | $410,000 | -13.1% | 5,635 | -5.7% | 0.24% | +65.0% |
Q3 2016 | $472,000 | -7.5% | 5,974 | -3.5% | 0.14% | -52.8% |
Q2 2016 | $510,000 | +15.9% | 6,190 | +1.9% | 0.30% | +4.5% |
Q1 2016 | $440,000 | -15.9% | 6,075 | 0.0% | 0.29% | -23.5% |
Q4 2015 | $523,000 | -5.3% | 6,075 | +1.2% | 0.38% | -13.3% |
Q3 2015 | $552,000 | -1.4% | 6,000 | -1.6% | 0.44% | +2.3% |
Q2 2015 | $560,000 | -8.5% | 6,100 | -1.7% | 0.43% | -7.8% |
Q1 2015 | $612,000 | +6.4% | 6,205 | 0.0% | 0.46% | -1.9% |
Q4 2014 | $575,000 | – | 6,205 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |